UK – Further guidance note on the regulation of medicines, medical devices and clinical trials in a no-deal Brexit

Information for stakeholders so you can make informed plans and preparations in the event of leaving the EU with no deal.

This guidance is intended to update stakeholders on the UK’s proposed arrangements for the regulation of medicines, medical devices and clinical trials…